about
Primary brain tumors, neural stem cell, and brain tumor cancer cells: where is the link?Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.Enhanced antitumor efficacy of an oncolytic herpes simplex virus expressing an endostatin-angiostatin fusion gene in human glioblastoma stem cell xenografts.Neural stem cell-based cell carriers enhance therapeutic efficacy of an oncolytic adenovirus in an orthotopic mouse model of human glioblastoma.Dendritic Cell-Based Vaccines that Utilize Myeloid Rather than Plasmacytoid Cells Offer a Superior Survival Advantage in Malignant Glioma.Isorhapontigenin suppresses growth of patient-derived glioblastoma spheres through regulating miR-145/SOX2/cyclin D1 axis.Glioma Stem Cells but Not Bulk Glioma Cells Upregulate IL-6 Secretion in Microglia/Brain Macrophages via Toll-like Receptor 4 Signaling.Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells.Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.Targeting cancer stem cells for treatment of glioblastoma multiforme.Antiglioma oncolytic virotherapy: unattainable goal or a success story in the making?Repurposing some older drugs that cross the blood-brain barrier and have potential anticancer activity to provide new treatment options for glioblastoma.Velogenic newcastle disease virus as an oncolytic virotherapeutics: in vitro characterization.Survivin a radiogenetic promoter for glioblastoma viral gene therapy independently from CArG motifs.Hepatocyte nuclear factor 1 beta induces transformation and epithelial-to-mesenchymal transition.
P2860
Q33729734-1439C6D6-6349-4801-B2E4-5426EB8E586DQ33923950-67F04E1B-FC54-4AD6-8A53-6240C9B01238Q35155160-FC8725E6-28BD-4E51-9463-72125129C1C2Q35238250-8CD3AB32-34DA-4B93-A9BC-F9E25585FF15Q35763478-4568B769-F279-43E6-9826-2FE08A5D75A9Q36893240-A01957A7-EA41-41D4-98E8-1180A3DE2ECEQ37228242-D074AC5A-FBC8-4BB7-A997-09D6C7A9E72FQ37603641-0112B397-A3AE-4C61-ACC7-22B6F6CB542CQ37804933-AF59794F-4530-4630-9414-BA2E3F93F2C5Q38099729-70A64B5F-339C-4E5B-B495-2A764165B118Q38218674-29BC380A-8092-4106-8B2E-4753D900B622Q38587724-C07684E8-8913-4B3A-A6EB-9CD4A9DCA4F6Q39611522-77C8116F-F263-4B1E-8843-BE5C82431EE6Q40311561-726D2206-927F-498E-9B60-D5D718BE1464Q51427443-EE40EB85-3454-4659-8E22-4ED6995FB887
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Virotherapy against malignant glioma stem cells
@ast
Virotherapy against malignant glioma stem cells
@en
type
label
Virotherapy against malignant glioma stem cells
@ast
Virotherapy against malignant glioma stem cells
@en
prefLabel
Virotherapy against malignant glioma stem cells
@ast
Virotherapy against malignant glioma stem cells
@en
P2093
P2860
P1433
P1476
Virotherapy against malignant glioma stem cells
@en
P2093
Ilya V Ulasov
Maciej S Lesniak
P2860
P356
10.1016/J.CANLET.2009.04.045
P407
P577
2009-07-29T00:00:00Z